What the amendment changed
Compared with the return it replaced , filed 22 October 2024. matched by us Only the return's totals, a 990-PF's accounting method and the names listed in Part VII (Part VIII on a 990-PF) are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.
Listed only on the later return
- Daniel Rice
- Jeffrey Kaufman
- Tiffany Tzeng
Totals
- Total revenue
- $4,319,125
- Total expenses
- $2,853,790
- Contributions and grants received
- $4,245,450
- Grants paid
- $0
- Program service revenue
- $18,529
- Investment income
- $52,990
- Other revenue
- $2,156
- Total assets, end of year
- $4,855,240
- Total liabilities, end of year
- $140,051
- Net assets or fund balances, end of year
- $4,715,189
- Program services expenses (Part IX)
- $2,323,496
- Management and general expenses
- $530,294
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $2,323,496
Program services were 81.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$4,245,450
-
1g · Noncash contributions included above
$444,795
-
2a · Program service revenue: program consulting
total $18,529 · related or exempt $18,529
-
3 · Investment income
total $52,990 · excluded $52,990
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6d · Net rental income or loss
total $0
-
7d · Net gain or loss
total $0
-
8c · Net income from fundraising events
total $0
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11a · Other revenue: Other Income
total $2,156 · excluded $2,156
-
11e · Other revenue, total
$2,156
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $0
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $8,400 · program services $8,400
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $621,430 · program services $474,010 · management and general $147,420
-
8 · Pension plan contributions
total $0
-
9 · Other employee benefits
total $48,640 · program services $37,179 · management and general $11,461
-
10 · Payroll taxes
total $47,067 · program services $36,083 · management and general $10,984
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $119,898 · program services $15,858 · management and general $104,040
-
11c · Fees: accounting
total $31,709 · management and general $31,709
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $1,544,973 · program services $1,533,665 · management and general $11,308
-
12 · Advertising and promotion
total $0
-
13 · Office expenses
total $138,707 · program services $28,092 · management and general $110,615
-
14 · Information technology
total $0
-
15 · Royalties
total $0
-
16 · Occupancy
total $0
-
17 · Travel
total $53,386 · program services $26,474 · management and general $26,912
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $7,477 · program services $6,692 · management and general $785
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $191,506 · program services $145,947 · management and general $45,559
-
23 · Insurance
total $1,825 · management and general $1,825
-
24a · Other expenses: equipment & technology
total $14,210 · program services $465 · management and general $13,745
-
24b · Other expenses: meals
total $9,484 · program services $1,032 · management and general $8,452
-
24c · Other expenses: payroll processing fees
total $6,560 · program services $5,110 · management and general $1,450
-
24d · Other expenses: filing fees
total $2,878 · program services $2,698 · management and general $180
-
24e · All other expenses
total $5,640 · program services $1,791 · management and general $3,849
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $2,562,780 · end of year $3,586,153
-
2 · Savings and temporary cash investments
end of year $0
-
3 · Pledges and grants receivable
end of year $382,747
-
4 · Accounts receivable
end of year $18,529
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
end of year $0
-
10a · Land, buildings and equipment: cost or other basis
$1,093,369
-
10b · Land, buildings and equipment: accumulated depreciation
$225,558
-
10c · Land, buildings and equipment, net
beginning of year $699,074 · end of year $867,811
-
11 · Investments: publicly traded securities
end of year $0
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
end of year $0
-
17 · Accounts payable and accrued expenses
beginning of year $12,000 · end of year $140,051
-
27 · Net assets without donor restrictions
beginning of year $3,249,854 · end of year $3,579,633
-
28 · Net assets with donor restrictions
end of year $1,135,556
Mission and programs · 2023
Mission
To reduce catastrophic risks from novel biotechnologies by conducting research on pandemic prevention, detection, and mitigation.
-
As part of its SecureDNA project, the organization made significant progress in 2023 on its gene synthesis screening software. The team released an alpha version and prepared for a public beta launch. This free software offers best-in-class performance in screening criteria and runs against a continuously updated hazard database. SecureDNA uniquely integrates with both vendor order flows and benchtop synthesizers. The organization successfully tested with major manufacturers and collaborated with leading gene synthesis companies in the US and China. Two papers were prepared for submission to Nature, one on the screening system and another on its cryptographic architecture. These advancements further the organization's goal of securely monitoring synthetic DNA orders against various public health hazards.
Expenses $1,342,801
-
As part of its work on the Nucleic Acid Observatory (NAO) project, the organization runs experiments to detect metagenomic sequences in wasterwater, with the ultimate aim of detecting new diseases before they grow exponentially in the community. In 2023, The NAO team conducted a major experiment, collecting wastewater samples from a prominent US airport and one of the nation's largest wastewater treatment plants. This rich dataset is slated for analysis in the coming year. The team expanded its research output, publishing a paper on pathogen abundance as a function of disease prevalence, building upon their previous report on the topic. Additionally, they released a paper on virus-like phagemids, which were designed and built in-house to experimentally characterize wastewater-based pathogen monitoring systems. To accelerate disease detection capabilities in wastewater, the organization initiated work on a more immediate NAO pilot project, focusing on specific pathogens rather than the full-scale, pathogen-agnostic approach of the primary NAO initiative.
Expenses $752,022
-
As part of its work on the FAR-UVC project, the organization conducted an in-depth examination of the safety of far-UVC germicidal light throughout 2023. This comprehensive study involved convening a group of experts for both in-person and remote workshops over a 12-month period. The culmination of this extensive research was the release of a major paper on far-UVC safety, effectively concluding the organization's work on this project. While the organization designed a clinical study to further investigate the application of far-UVC technology, it determined that executing such a trial was not feasible given the available resources. This decision marked the completion of the organization's active involvement in the FAR-UVC research initiative.
Expenses $108,255
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Jeffrey Kaufman
NAO Project Lead
- Total calculated
- $150,353
- From this org
- $144,989
- From related orgs
- $0
- Other
- $5,364
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $144,989
- Bonus
- not reported
- Other
- not reported
- Deferred
- $4,108
- Nontaxable benefits
- $1,256
- Filer's total
- $150,353
-
Tiffany Tzeng
Operations Manager
- Total calculated
- $128,540
- From this org
- $116,071
- From related orgs
- $0
- Other
- $12,469
- Hours/week
- 40
-
Daniel Rice
Research Scientist
- Total calculated
- $124,382
- From this org
- $119,826
- From related orgs
- $0
- Other
- $4,556
- Hours/week
- 40
-
Vaishnav Sunil
Treasurer
- Total calculated
- $8,400
- From this org
- $8,400
- From related orgs
- $0
- Other
- $0
- Hours/week
- 4
-
Benjamin Mueller
Executive Dir.
- Total calculated
- $0
- Hours/week
- 1
-
Kevin Esvelt
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Sawyer Bernath
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
William Bradshaw
Secretary
- Total calculated
- $0
- Hours/week
- 4
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 15 November 2024
- IRS schema version
- 2023v5.1
- Source object
- 202413209349312686
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.